Aprea Therapeutics, Inc. (APRE)
0.9167
+0.04
(+4.16%)
USD |
NASDAQ |
Feb 27, 16:00
0.901
-0.02
(-1.71%)
After-Hours: 20:00
Aprea Therapeutics EPS Diluted (Quarterly) : -0.4664 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Modular Medical, Inc. | -0.1116 |
| Ernexa Therapeutics, Inc. | -0.1507 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| Tango Therapeutics, Inc. | 0.1431 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.972M |
| Revenue (Quarterly) | 0.0018M |
| Total Expenses (Quarterly) | 2.974M |
| Enterprise Value | -6.580M |
| Gross Profit Margin (Quarterly) | -200.0% |
| Profit Margin (Quarterly) | -165.1K% |
| Earnings Yield | -233.6% |
| Normalized Earnings Yield | -233.57 |